As of April 29, 2025, AlloVir (ALVR) has a market cap of $49.475 million USD. According to our data, AlloVir is ranked No.8110 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $49.48 M |
1.60%
|
Dec 31, 2024 | $48.69 M |
-38.24%
|
Dec 29, 2023 | $78.84 M |
-86.74%
|
Dec 30, 2022 | $0.59 B |
-60.36%
|
Dec 31, 2021 | $1.50 B |
-66.34%
|
Dec 31, 2020 | $4.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$44.00 M |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Mesoblast
MESO
|
$1.51 B |
0.786 M
|
![]() Australia
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() Vir Biotechnology
VIR
|
$0.83 B |
-0.000 M
|
![]() USA
|
Market Cap | = | ALVR Stock Price | * | ALVR Shares Outstanding |
= | $9.81 | * | 5.04 M | |
= | $49.48 M |